People taking anticoagulants such as warfarin, apixaban, or rivaroxaban face compounded bleeding risk
News Peg Novo Nordisk ended a separate trial of the drug looking at kidney disease last year far earlier than originally expected on account of the positive results
Simon analyze commercial insurance claims for approximately 537,000 patients who initiated GLP-1 treatment between 2017 and 2022
Readers wanting what's brand-stated, what research supports, and what to confirm before ordering - keep reading
In one study, repeated topical 5% DHA application in hairless dogs led to irritant contact dermatitis, with histopathological findings of epidermal thickening, degeneration, and inflammatory changes, while vehicle-only controls showed no such effects, indicating DHA as the causative agent